Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.

Photys

(To Be Hired)

Bryan Song

Ed Holson

Emma Seabrook

The leadership team at Photys has experience in a variety of industries, including venture advising, medical research, and talent recruitment. They have also educated at some of the top universities in the country, including the University of Michigan and The University of Texas at Austin. This experience and education gives them the knowledge and skills necessary to lead Photys into the future.

Leadership Team

About

Team members

Other teams at Photys

CEO and Executive Team